Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase

被引:131
作者
Elkins, PA [1 ]
Ho, YS
Smith, WW
Janson, CA
D'Alessio, KJ
McQueney, MS
Cummings, MD
Romanic, AM
机构
[1] GlaxoSmithKline, King Of Prussia, PA 19406 USA
[2] 3 Dimens Pharmaceut, Exton, PA 19341 USA
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2002年 / 58卷
关键词
D O I
10.1107/S0907444902007849
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The X-ray crystal structure of the proform of human matrix metalloproteinase MMP9 has been solved to 2.5 Angstrom resolution. The construct includes the prodomain, the catalytic domain and three FnII (fibronectin type II) domains. The prodomain is inserted into the active-site cleft, blocking access to the catalytic zinc. Comparison with the crystal structure of the most closely related MMP, MMP2, indicates that the conformations of residues in the active-site cleft and in the cysteine-switch peptide of the prodomain are highly conserved and that design of MMP9-specific inhibitors will be challenging. In common with MMP2, the MMP9 S1' inhibitor-binding pocket is large compared with that of other MMPs. One small point of difference in the S1' binding pockets of MMP9 and MMP2 may provide an opportunity to explore the design of specific inhibitors. The side chain of Arg424 in MMP9 is angled slightly away from the S1' pocket when compared with the corresponding residue in MMP2, Thr424. The secondary structure of the FnII domains is conserved between the two closely related MMPs, although the second FnII domain makes no contact with the catalytic domain in MMP9, while the same domain in MMP2 has a substantial area of interaction with the catalytic domain.
引用
收藏
页码:1182 / 1192
页数:11
相关论文
共 52 条
[51]   Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells [J].
Yao, J ;
Xiong, SB ;
Klos, K ;
Nguyen, N ;
Grijalva, R ;
Li, P ;
Yu, D .
ONCOGENE, 2001, 20 (56) :8066-8074
[52]   Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues - Clinical and experimental applications [J].
Zucker, S ;
Hymowitz, M ;
Conner, C ;
Zarrabi, HM ;
Hurewitz, AN ;
Matrisian, L ;
Boyd, D ;
Nicolson, G ;
Montana, S .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :212-227